IRB Seminar - Marco Prunotto, Senior Clinical Development Scientist, Office of Innovation Immunology, Infectious Diseases & Ophthalmology (I2O), Roche and Genentech Late Stage Development, Hoffmann-La Roche AG, Basel, CH
Institute for Research in Biomedicine
Date: 21 November 2018 / 12:00 - 13:00
Marco Prunotto, Ph.D
"Identification of Target Antigens in Sera of Membranous Nephropathy Patients Using Whole Proteome Peptide Array Technology"
Senior Clinical Development Scientist, Office of Innovation Immunology, Infectious Diseases & Ophthalmology (I2O), Roche and Genentech Late Stage Development, Hoffmann-La Roche AG, Basel, Switzerland
Wednesday, November 21, 2018 at 12.00
IRB Conference Room
Institute for Research in Biomedicine (IRB)
Via Vincenzo Vela 6
CH-6500 Bellinzona
